Cargando…

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center

BACKGROUND AND AIMS: The standard treatment of non-metastatic anal squamous cell carcinoma (ASCC) consists of chemotherapy with mitomycin (MMC) plus 5-fluorouracil (5FU) for 1–2 cycles concomitant with pelvic radiotherapy. Subsequent studies introduced cisplatin (CDDP) combined with 5FU, with unclea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rotundo, Maria Saveria, Zampino, Maria Giulia, Ravenda, Paola Simona, Bagnardi, Vincenzo, Peveri, Giulia, Dell’Acqua, Veronica, Surgo, Alessia, Trovato, Cristina, Bottiglieri, Luca, Bertani, Emilio, Petz, Wanda Luisa, Fumagalli Romario, Uberto, Fazio, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364808/ https://www.ncbi.nlm.nih.gov/pubmed/32728394 http://dx.doi.org/10.1177/1758835920940945

Ejemplares similares

Human papillomavirus in anal squamous cell carcinoma: an angel rather than a devil?
por: Ravenda, Paola Simona, et al.
Publicado: (2015)

PD-1/PD-L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials
por: Rotundo, Maria Saveria, et al.
Publicado: (2022)

Updates on Robotic CME for Right Colon Cancer: A Qualitative Systematic Review
por: Petz, Wanda, et al.
Publicado: (2021)

Side-to-side esophagogastric anastomosis for minimally invasive Ivor-Lewis esophagectomy: operative technique and short-term outcomes
por: Fabbi, Manrica, et al.
Publicado: (2021)

Location and condition based reconstruction of colon cancer microbiome from human RNA sequencing data
por: Sambruni, Gaia, et al.
Publicado: (2023)

Immune inflammation indicators in anal cancer patients treated with concurrent chemoradiation: training and validation cohort with online calculator (ARC: Anal Cancer Response Classifier)
por: Casadei-Gardini, Andrea, et al.
Publicado: (2019)

Personality Factors in Colorectal Cancer: A Systematic Review
por: Galli, Federica, et al.
Publicado: (2021)

Dose–response relationship between cigarette smoking and site-specific cancer risk: protocol for a systematic review with an original design combining umbrella and traditional reviews
por: Lugo, Alessandra, et al.
Publicado: (2017)

COVID-19: Effect on patients with gastrointestinal cancer and surgery
por: Ghidinelli, Federico, et al.
Publicado: (2020)

Implementation of the ERAS program in gastric surgery: a nationwide survey in Italy
por: Romario, Uberto Fumagalli, et al.
Publicado: (2022)

Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option
por: Meulendijks, D, et al.
Publicado: (2014)

GZMK(high) CD8(+) T effector memory cells are associated with CD15(high) neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
por: Tiberti, Silvia, et al.
Publicado: (2022)

Author Correction: GZMK(high) CD8(+) T effector memory cells are associated with CD15(high) neutrophil abundance in non-metastatic colorectal tumors and predict poor clinical outcome
por: Tiberti, Silvia, et al.
Publicado: (2022)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)
por: Laffi, Alice, et al.
Publicado: (2023)

Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma
por: Thind, Govin, et al.
Publicado: (2014)

Preliminary results on anal cancer by applying intensity modulated radiotherapy and synchronous capecitabine chemotherapy simultaneously
por: Xu, Wei-Dong, et al.
Publicado: (2020)

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma
por: Zampino, Maria G, et al.
Publicado: (2011)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor
por: Muraglia, Lorenzo, et al.
Publicado: (2023)

Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients
por: Andreoni, Bruno, et al.
Publicado: (2007)

Replacing 5-fluorouracil by capecitabine in localised squamous cell carcinoma of the anal canal: systematic review and meta-analysis
por: Souza, Karla T, et al.
Publicado: (2016)

mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials
por: Rotundo, Maria Saveria, et al.
Publicado: (2016)

Childbearing and Delivery in Women With Ulcerative Colitis and Ileostomy or Ileal Pouch-Anal Anastomosis
por: Campigotto, Michele, et al.
Publicado: (2022)

Tips and Tricks for Early Diagnosis of Cervico-Vaginal Involvement from Extramammary Paget’s Disease of the Vulva: A Referral Center Experience
por: Iacobone, Anna Daniela, et al.
Publicado: (2023)

Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
por: Calvello, Mariarosaria, et al.
Publicado: (2023)

Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer
por: Mineur, Laurent, et al.
Publicado: (2023)

Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial
por: Monti, Manlio, et al.
Publicado: (2020)

Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation
por: Stefanelli, Berenice, et al.
Publicado: (2022)

The Prognostic Value of the New Combined Hemo-Eosinophil Inflammation Index (HEI Index): A Multicenter Analysis of Anal Cancer Patients Treated with Concurrent Chemo-Radiation
por: Rimini, Margherita, et al.
Publicado: (2021)

Diaphragmatic hernia after Ivor Lewis esophagectomy for cancer: a retrospective analysis of risk factors and post-repair outcomes
por: Puccetti, Francesco, et al.
Publicado: (2021)

Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne
por: Casella, Francesco, et al.
Publicado: (2022)

Status of simulation studies for fibre calorimetry
por: Vercesi, V, et al.
Publicado: (1990)

Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Primary pure gastric yolk sac tumor
por: Magni, Elena, et al.
Publicado: (2010)

Concomitant (177)Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
por: Yadav, Madhav Prasad, et al.
Publicado: (2019)

Oral Capecitabine-Vinorelbine Is Associated with Longer Overall Survival When Compared to Single-Agent Capecitabine in Patients with Hormone Receptor-Positive Advanced Breast Cancer
por: Vernieri, Claudio, et al.
Publicado: (2020)

Double indocyanine green technique of robotic right colectomy: Introduction of a new technique
por: Kobiela, Jarek, et al.
Publicado: (2019)

The Prognostic Impact of Histology in Esophageal and Esophago-Gastric Junction Adenocarcinoma
por: Fiocca, Roberto, et al.
Publicado: (2021)

Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer
por: Correale, Pierpaolo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sk9t2vrbomkdnhcq6a97vpc36i